Competitive Landscape of Immune Checkpoint Inhibitors: North Americas Dominance in the Market will Remain Unchallenged during 2017-2026
Press Release – 10
Jan 2019
Research
and Development News
--
.
.
Latest
Update
"Global Market Study on Immune Checkpoint Inhibitors: North
Americas Dominance in the Market will Remain Unchallenged during
2017-2026"
with Industries Survey | Global Current Growth and Future.
'
'
Report Structure
The report starts with a chapter on executive summary of global Immune checkpoint inhibitors market, which highlights key research findings, especially across drug class and regional segments. A snapshot of the market size estimations, along with the forecast evaluations has been provided in this chapter. The report also offers an overview of the market, including standard definition of Immune checkpoint inhibitors coupled with a brief introduction of the market on the basis of analytical assessment.
The report starts with a chapter on executive summary of global Immune checkpoint inhibitors market, which highlights key research findings, especially across drug class and regional segments. A snapshot of the market size estimations, along with the forecast evaluations has been provided in this chapter. The report also offers an overview of the market, including standard definition of Immune checkpoint inhibitors coupled with a brief introduction of the market on the basis of analytical assessment.
'
'
The report
offers market size estimations & forecast in terms of key metrics
including compounded annual growth rate, year-on-year growth rate,
basis point share index, and absolute dollar opportunity. Moving
further, the report studies dynamic expansion of the global Immune
checkpoint inhibitors market. This chapter provides analysis on
factors restraining or driving the worldwide adoption of Immune
checkpoint inhibitors. Lucrative opportunities and key trends are
compiled in this chapter for enabling market players in considering
the untapped entities for expansion of their business in the
immediate future.
Competition Landscape
Last chapters in the report offer knowledge about global immune checkpoint inhibitors markets competition landscape. In these chapters, the report delivers Information pertaining to the market players in terms of product overview, SWOT analysis, key developments, company overview, and key financials of the market players. Chapters on the markets competition landscape are considered to be an indispensable part of the report, which provide readers with access to a detailed knowledge base to help them understand the past and current standings of prominent industries that actively contribute to global immune checkpoint inhibitors markets expansion. These chapters of the report offer essential information about the way of players strategy implementation through which they aim in increasing their global market presence.
Competition Landscape
Last chapters in the report offer knowledge about global immune checkpoint inhibitors markets competition landscape. In these chapters, the report delivers Information pertaining to the market players in terms of product overview, SWOT analysis, key developments, company overview, and key financials of the market players. Chapters on the markets competition landscape are considered to be an indispensable part of the report, which provide readers with access to a detailed knowledge base to help them understand the past and current standings of prominent industries that actively contribute to global immune checkpoint inhibitors markets expansion. These chapters of the report offer essential information about the way of players strategy implementation through which they aim in increasing their global market presence.
– For
Other Requirement and Enquiry_
https://www.researchmoz.us/enquiry.php?type=E&repid=1834368
'
'
Research
Methodology
Analysts at PMR have developed a comprehensive research methodology to come up with credible insights on future of various markets. Immune checkpoint inhibitors is more likely an emerging development in treatment of cancers, and is witnessing applications in the global healthcare marketplace. For developing this report, accuracy of these forecast market evaluations are assured by infusing the qualitative information with the quantitative data. Inferences delivered in this report may enable developers of Immune checkpoint inhibitors for devising informed strategies. A wide range of primary as well as secondary research methodologies have been employed for developing these inferences. Opinions of key industry leaders are assessed for validating viewpoints of PMRs analysts. By availing this report, companies can easily take informed decisions regarding future market direction.
Analysts at PMR have developed a comprehensive research methodology to come up with credible insights on future of various markets. Immune checkpoint inhibitors is more likely an emerging development in treatment of cancers, and is witnessing applications in the global healthcare marketplace. For developing this report, accuracy of these forecast market evaluations are assured by infusing the qualitative information with the quantitative data. Inferences delivered in this report may enable developers of Immune checkpoint inhibitors for devising informed strategies. A wide range of primary as well as secondary research methodologies have been employed for developing these inferences. Opinions of key industry leaders are assessed for validating viewpoints of PMRs analysts. By availing this report, companies can easily take informed decisions regarding future market direction.
Table of
Content
Chapter 1 Global Outlook
1.1 Pharmaceutical Industry: Global Outlook
Chapter 2 Global Immune Checkpoint Inhibitors Market - Executive Summary
Chapter 3 Global Immune Checkpoint Inhibitors Market Overview
3.1 Introduction
3.1.1 Global Immune Checkpoint Inhibitors Market Taxonomy
3.1.2 Global Immune Checkpoint Inhibitors Market Definition
3.2 Global Immune Checkpoint Inhibitors Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1 Global Immune Checkpoint Inhibitors Market Y-o-Y Growth
3.3 Global Immune Checkpoint Inhibitors Market Dynamics
3.4 Supply Chain
3.5 PESTLE Analysis
3.6 Regionwise Market Positioning Assessment
3.7 Porters Five Forces Analysis
3.8 Pipeline Assessment
3.8.1 AstraZeneca Plc.
3.8.2 Bristol-Myers Squib
3.8.3 Celldex Therapeutics Inc.
3.8.4 Roche Holdings AG
3.8.5 Merck & Co., Inc.
3.8.6 Merck KgaA & Pfizer Inc.
3.8.7 Sanofi
3.9 Reimbursement Support Scenario
3.9.1 OPDIVO (nivolumab) & YERVOY (ipilimumab)
3.9.2 Tecentriq
3.9.3 KEYTRUDA (pembrolizumab)
3.10 Key Participants Market Presence (Intensity Map) By Region
Chapter 4 Global Immune Checkpoint Inhibitors Market Analysis and Forecast 2012-2026
4.1 Global Immune Checkpoint Inhibitors Market Size and Forecast by Drug Class, 2012-2026
4.1.1 PD-1 Market Size and Forecast, 2012-2026
4.1.1.1 Revenue (US$ Mn) Comparison, By Region
4.1.1.2 Market Share Comparison, By Region
4.1.1.3 Y-o-Y growth Comparison, By Region
4.1.2 PD-L1 Market Size and Forecast, 2012-2026
4.1.2.1 Revenue (US$ Mn) Comparison, By Region
4.1.2.2 Market Share Comparison, By Region
4.1.2.3 Y-o-Y growth Comparison, By Region
4.1.3 CTLA-4 Market Size and Forecast, 2012-2026
4.1.3.1 Revenue (US$ Mn) Comparison, By Region
4.1.3.2 Market Share Comparison, By Region
4.1.3.3 Y-o-Y growth Comparison, By Region
4.2 Global Immune Checkpoint Inhibitors Market Size and Forecast by Distribution Channel, 2012-2026
4.2.1 Hospital Pharmacies Market Size and Forecast, 2012-2026
4.2.1.1 Revenue (US$ Mn) Comparison, By Region
4.2.1.2 Market Share Comparison, By Region
4.2.1.3 Y-o-Y growth Comparison, By Region
4.2.2 Retail Pharmacies Market Size and Forecast, 2012-2026
4.2.2.1 Revenue (US$ Mn) Comparison, By Region
4.2.2.2 Market Share Comparison, By Region
4.2.2.3 Y-o-Y growth Comparison, By Region
4.2.3 Specialty Pharmacies Market Size and Forecast, 2012-2026
4.2.3.1 Revenue (US$ Mn) Comparison, By Region
4.2.3.2 Market Share Comparison, By Region
4.2.3.3 Y-o-Y growth Comparison, By Region
4.3 Global Immune Checkpoint Inhibitors Market Size and Forecast by Therapeutic Application, 2012-2026
4.3.1 Melanoma Market Size and Forecast, 2012-2026
4.3.1.1 Revenue (US$ Mn) Comparison, By Region
4.3.1.2 Market Share Comparison, By Region
4.3.1.3 Y-o-Y growth Comparison, By Region
4.3.2 Lung Cancer Market Size and Forecast, 2012-2026
4.3.2.1 Revenue (US$ Mn) Comparison, By Region
4.3.2.2 Market Share Comparison, By Region
4.3.2.3 Y-o-Y growth Comparison, By Region
4.3.3 Blood Cancers Market Size and Forecast, 2012-2026
4.3.3.1 Revenue (US$ Mn) Comparison, By Region
4.3.3.2 Market Share Comparison, By Region
4.3.3.3 Y-o-Y growth Comparison, By Region
4.3.4 Renal Cell Carcinoma Market Size and Forecast, 2012-2026
4.3.4.1 Revenue (US$ Mn) Comparison, By Region
4.3.4.2 Market Share Comparison, By Region
4.3.4.3 Y-o-Y growth Comparison, By Region
4.3.5 Squamous Cell Carcinoma Market Size and Forecast, 2012-2026
4.3.5.1 Revenue (US$ Mn) Comparison, By Region
4.3.5.2 Market Share Comparison, By Region
4.3.5.3 Y-o-Y growth Comparison, By Region
4.3.6 Urothelial Carcinoma Market Size and Forecast, 2012-2026
4.3.6.1 Revenue (US$ Mn) Comparison, By Region
4.3.6.2 Market Share Comparison, By Region
4.3.6.3 Y-o-Y growth Comparison, By Region
4.3.7 Colorectal Cancer Market Size and Forecast, 2012-2026
4.3.7.1 Revenue (US$ Mn) Comparison, By Region
4.3.7.2 Market Share Comparison, By Region
4.3.7.3 Y-o-Y growth Comparison, By Region
4.3.8 Other Cancers Market Size and Forecast, 2012-2026
4.3.8.1 Revenue (US$ Mn) Comparison, By Region
4.3.8.2 Market Share Comparison, By Region
4.3.8.3 Y-o-Y growth Comparison, By Region
Chapter 1 Global Outlook
1.1 Pharmaceutical Industry: Global Outlook
Chapter 2 Global Immune Checkpoint Inhibitors Market - Executive Summary
Chapter 3 Global Immune Checkpoint Inhibitors Market Overview
3.1 Introduction
3.1.1 Global Immune Checkpoint Inhibitors Market Taxonomy
3.1.2 Global Immune Checkpoint Inhibitors Market Definition
3.2 Global Immune Checkpoint Inhibitors Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1 Global Immune Checkpoint Inhibitors Market Y-o-Y Growth
3.3 Global Immune Checkpoint Inhibitors Market Dynamics
3.4 Supply Chain
3.5 PESTLE Analysis
3.6 Regionwise Market Positioning Assessment
3.7 Porters Five Forces Analysis
3.8 Pipeline Assessment
3.8.1 AstraZeneca Plc.
3.8.2 Bristol-Myers Squib
3.8.3 Celldex Therapeutics Inc.
3.8.4 Roche Holdings AG
3.8.5 Merck & Co., Inc.
3.8.6 Merck KgaA & Pfizer Inc.
3.8.7 Sanofi
3.9 Reimbursement Support Scenario
3.9.1 OPDIVO (nivolumab) & YERVOY (ipilimumab)
3.9.2 Tecentriq
3.9.3 KEYTRUDA (pembrolizumab)
3.10 Key Participants Market Presence (Intensity Map) By Region
Chapter 4 Global Immune Checkpoint Inhibitors Market Analysis and Forecast 2012-2026
4.1 Global Immune Checkpoint Inhibitors Market Size and Forecast by Drug Class, 2012-2026
4.1.1 PD-1 Market Size and Forecast, 2012-2026
4.1.1.1 Revenue (US$ Mn) Comparison, By Region
4.1.1.2 Market Share Comparison, By Region
4.1.1.3 Y-o-Y growth Comparison, By Region
4.1.2 PD-L1 Market Size and Forecast, 2012-2026
4.1.2.1 Revenue (US$ Mn) Comparison, By Region
4.1.2.2 Market Share Comparison, By Region
4.1.2.3 Y-o-Y growth Comparison, By Region
4.1.3 CTLA-4 Market Size and Forecast, 2012-2026
4.1.3.1 Revenue (US$ Mn) Comparison, By Region
4.1.3.2 Market Share Comparison, By Region
4.1.3.3 Y-o-Y growth Comparison, By Region
4.2 Global Immune Checkpoint Inhibitors Market Size and Forecast by Distribution Channel, 2012-2026
4.2.1 Hospital Pharmacies Market Size and Forecast, 2012-2026
4.2.1.1 Revenue (US$ Mn) Comparison, By Region
4.2.1.2 Market Share Comparison, By Region
4.2.1.3 Y-o-Y growth Comparison, By Region
4.2.2 Retail Pharmacies Market Size and Forecast, 2012-2026
4.2.2.1 Revenue (US$ Mn) Comparison, By Region
4.2.2.2 Market Share Comparison, By Region
4.2.2.3 Y-o-Y growth Comparison, By Region
4.2.3 Specialty Pharmacies Market Size and Forecast, 2012-2026
4.2.3.1 Revenue (US$ Mn) Comparison, By Region
4.2.3.2 Market Share Comparison, By Region
4.2.3.3 Y-o-Y growth Comparison, By Region
4.3 Global Immune Checkpoint Inhibitors Market Size and Forecast by Therapeutic Application, 2012-2026
4.3.1 Melanoma Market Size and Forecast, 2012-2026
4.3.1.1 Revenue (US$ Mn) Comparison, By Region
4.3.1.2 Market Share Comparison, By Region
4.3.1.3 Y-o-Y growth Comparison, By Region
4.3.2 Lung Cancer Market Size and Forecast, 2012-2026
4.3.2.1 Revenue (US$ Mn) Comparison, By Region
4.3.2.2 Market Share Comparison, By Region
4.3.2.3 Y-o-Y growth Comparison, By Region
4.3.3 Blood Cancers Market Size and Forecast, 2012-2026
4.3.3.1 Revenue (US$ Mn) Comparison, By Region
4.3.3.2 Market Share Comparison, By Region
4.3.3.3 Y-o-Y growth Comparison, By Region
4.3.4 Renal Cell Carcinoma Market Size and Forecast, 2012-2026
4.3.4.1 Revenue (US$ Mn) Comparison, By Region
4.3.4.2 Market Share Comparison, By Region
4.3.4.3 Y-o-Y growth Comparison, By Region
4.3.5 Squamous Cell Carcinoma Market Size and Forecast, 2012-2026
4.3.5.1 Revenue (US$ Mn) Comparison, By Region
4.3.5.2 Market Share Comparison, By Region
4.3.5.3 Y-o-Y growth Comparison, By Region
4.3.6 Urothelial Carcinoma Market Size and Forecast, 2012-2026
4.3.6.1 Revenue (US$ Mn) Comparison, By Region
4.3.6.2 Market Share Comparison, By Region
4.3.6.3 Y-o-Y growth Comparison, By Region
4.3.7 Colorectal Cancer Market Size and Forecast, 2012-2026
4.3.7.1 Revenue (US$ Mn) Comparison, By Region
4.3.7.2 Market Share Comparison, By Region
4.3.7.3 Y-o-Y growth Comparison, By Region
4.3.8 Other Cancers Market Size and Forecast, 2012-2026
4.3.8.1 Revenue (US$ Mn) Comparison, By Region
4.3.8.2 Market Share Comparison, By Region
4.3.8.3 Y-o-Y growth Comparison, By Region
Continue.....
– More
Clear Details get Full Table of Contents_
https://www.researchmoz.us/global-market-study-on-immune-checkpoint-inhibitors-north-americas-dominance-in-the-market-will-remain-unchallenged-during-2017-2026-report.html/toc
About
Researchmoz,
ResearchMoz
is the world’s fastest growing collection of market research
reports worldwide. Our database is composed of current market studies
from over 100 featured publishers worldwide. Our market research
databases integrate statistics with analysis from global, regional,
country and company perspectives. ResearchMoz’s service portfolio
also includes value-added services such as market research
customization, competitive landscaping, and in-depth surveys,
delivered by a team of experienced Research
Coordinators.
--Researchmoz Global Pvt. Ltd.--
--Researchmoz Global Pvt. Ltd.--
Mr.
Nachiket G.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074www.researchmoz.us
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074www.researchmoz.us
Comments
Post a Comment